High profile mergers and acquisitions involving medical technology companies such as Indiana-based Zimmer Biomet kept a steady pace during the first part of 2025. Market observers and M&A attorneys are keeping a close eye to see if that continues for the rest of the year and into 2026. There were 57 M&A MedTech transactions announced in this year’s opening quarter, totaling more than $9.2 billion for companies developing medical devices, diagnostics, therapeutic digital health and commercial research tools. This compares to 62 transactions totaling $2.7 billion in the fourth quarter of 2024.
Read the full article: Zimmer Biomet Deal Reflects Strong Medtech M&A Activity, Attorneys and Analysts Say //
Source: https://www.theindianalawyer.com/articles/zimmer-biomet-deal-reflects-strong-medtech-ma-activity-attorneys-say